NCBS Home page
Accession List
Pathway List
Search
Authorized Users
Help
News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.
Search in: Search for Match By


 
Result: 1 - 8 of 8 rows are displayed

Molecule List for pathway Gs (Pathway Number 198) in Accession PKA_2003 (Accession Number 47)

Default ordering is done according to Pathway Number. Table headers can be used for changing the default ordering.
arrow indicates that ordering is done according to ascending or descending order.
The entries are grouped according to Pathway Number and are alternately color coded using  and  color.
  NameAccession
Type
Initial
Conc.

(uM)
Volume
(fL)
BufferedSum Total Of
1 GDP.GabcNetwork10No
    The resting state of Gs: GDP bound to trimer. From Pang and Sternweis JBC 265:30 18707-12 1990 we get conc est 1.6 uM to 0.8 uM. We'll use 1 uM.
2 RNetwork0.08330No
    A typical number of receptors per cell is about 50000.
3 L.RNetwork00No
    Ligand.Receptor complex
4 L.R.GDP.GabcNetwork00No
    This is the ternary complex, where all the action happens. There are actually a lot more steps here, including a final step where the GTP binds the L.R.Ga complex and causes the release of GTP.Ga from the L.R. For simplicity this is excluded.
5 GDP.GaNetwork00No
    The inactive GDP-bound form of Gs alpha.
6 GbgNetwork00No
    The Gbetagamma dimer.
7 R.GDP.GabcNetwork00No
    Fraction of R.GDP.Gabc is about 50% of total R, from Fay et al. Biochemistry 30:5066-5075(1991) Since this is not the same receptor, this value is a bit uncertain.
8 LNetwork00Yes
    This ligand could be any of several which bind to the beta adrenergic receptor and other G-protein coupled receptors which activate AC. For the sake of argument, call it isoproterenol.

 
Result: 1 - 8 of 8 rows are displayed



Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.